A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancerscRNA/TCR-seq analysis of 234 anti-PD-1-treated tumors identified immune heterogeneity associated with short-term pathological response and long-term recurrence-free survival.scRNA/TCR-seq analysis of 234 anti-PD-1-treated tumors identified immune heterogeneity associated with short-term pathological response and long-term recurrence-free survival.Zedao Liu, Zhenlin Yang, Junqi Wu, Wenjie Zhang, Yuxuan Sun, […]
Read more